Phio Pharmaceuticals PHIO
NASDAQ PHIO
$0.88 +0.01 (+0.85%)
As of: Oct 23, 2026 · 3:56 PM EDT

Phio Pharmaceuticals (PHIO) Deferred Taxes (2017)

Updated

Phio Pharmaceuticals' Deferred Taxes was -$1.62 million in FY2017.

Analysis

Phio Pharmaceuticals (PHIO) Deferred Taxes (2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 1.05 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn -1.79 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn -195.00 Mn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -544.00 Mn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn -
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn -
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn -291.00 Mn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -587.00 Mn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn -1.32 Bn
10 Phio Pharmaceuticals 10.22 Mn -51.54 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2017 -1.62 Mn
API Access

Phio Pharmaceuticals Deferred Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=deferred-taxes&ticker=PHIO&period=max&api_key=YOUR_API_KEY